Associated Papers
Clinical and functional characterization of a novel TNFRSF9 variant causing immune dysregulation with predisposition to EBV-driven lymphomagenesis.
Zhao P et al.
Frontiers in Immunology, 2025
CD137 deficiency because of two novel biallelic TNFRSF9 mutations in a patient presenting with severe EBV-associated lymphoproliferative disease.
Shen K et al.
Clinical & Translational Immunology, 2023
Select a paper to view details